Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Passage Bio Inc/
Recent news which mentions Passage Bio Inc/
Lab Notes: Wedgewood Pharmacy acquires Colorado lab; Aprea Therapeutics raises $5.5M
March 03, 2023
Tickers
INNO
Tags
Jennifer Travis
Health Care
Passage Bio Inc/
From
Business Journals
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
December 23, 2022
Tickers
INNO
Tags
Armando Anido
Kevin Heyeck
Pharmaceuticals
From
Business Journals
Lab notes: Adaptimmune to reduce workforce; NRx completes $11M debt financing
November 11, 2022
Tickers
INNO
Tags
Stephen Willard
Passage Bio Inc/
Nabriva Therapeutics plc Ireland
From
Business Journals
Lab Notes: Adaptimmune to expand manufacturing at Navy Yard; Helius raises $18M with stock sale
August 12, 2022
Tickers
INNO
Tags
Medical Devices
Roundup
Pharmaceuticals
From
Business Journals
Lab Notes: Mark Cuban increases investment in Strella Biotech as part of multimillion-dollar VC round
June 10, 2022
Tickers
INNO
Tags
Annovis Bio Inc/
Inno
Ray Cheng
From
Business Journals
Passage Bio trims workforce by 13%, narrows R&D focus to extend cash runway
March 15, 2022
Tags
Eliseo O/ Salinas
Pharmaceuticals
Insurance
From
Business Journals
Lab Notes: Optinose advances sinusitis drug-device combo; WuXi launches new technology
March 11, 2022
Tickers
INNO
Tags
Roundup
Pharmaceuticals
Medical Devices
From
Business Journals
Passage Bio further expands gene therapy research partnership with Penn
December 08, 2021
Tags
Penn Medicine (University of Pennsylvania Health System)
Pharmaceuticals
Biotech
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.